Complex karyotypes in childhood acute lymphoblastic leukemia: Cytogenetic and molecular cytogenetic study of 21 cases

Cancer Genetics and Cytogenetics

Volumn 145, Issue 2, 2003, Pages 161-168

  Jarosova M ^a   Holzerova M ^a   Mihal V ^b   Lakoma I ^a   Divoky V ^a   Blazek B ^c   Pospisilova D ^b   Hajduch M ^b   Novak Z ^b   Dusek L ^d   Koptikova J ^d   Poulsen, T S ^e   Indrak K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c Teaching Hospital   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHROMOSOME 11Q; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIPLOIDY; FEMALE; GENE DELETION; HUMAN; KARYOTYPE; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE;

EID: 0041662202     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00099-2     Document Type: Article

References (34)

1. Pui C.H., Crist W.M., Look A.T. Biology and clinical significance of cytogenetics abnormalities in childhood acute lymphoblastic leukemias. Blood. 76:1990;1449-1463.
2. Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia, 1980. Cancer Genet Cytogenet. 4:1981;111-137.
3. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
4. Secker-Walker L.M., Lawler S.D., Hardisty R.M. Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br Med J. 2:1978;1529-1532.
5. Williams D.L., Harber J., Murfy S.B., Look A.T., Kalwinsky D.K., Rivera G., Melvin S.L., Stass S., Dahl G.V. Chromosomal translocations play a unique role in prognosis in childhood acute lymphoblastic leukemia. Blood. 68:1986;205.
6. Pui C.H., Behm F.G., Singh B., Schell M.J., Williams D.L., Rivera G.K., Kalwinsky D.K., Sandlund J.T., Crist W.M., Raimondi S.C. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T- cell acute lymphoblastic leukemia. Blood. 75:1990;174-179.
7. Bloomfield C.D., Lindquist L.L., Arthur D., McKenna R.W., LeBien T.W., Pederson B.A., Nesbit M.A. Chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res. 41:1981;4838-4843.
8. ISCN 1995: an international system for human cytogenetic nomenclature. Mitelman F. 1995;S. Karger, Basel.
9. Mihál V., Jarošová M., Holzerová M., Jedličková K., Pikalová Z., Pospišilová D., Hajdúch M., Blažek B., Klodová D., Indrák K. Incidence and clinical outcome of children with complex karyotype abnormalities - positive acute lymphoblastic leukemia (ALL). Blood. 96:2000;4552.
10. Kallioniemi O.P., Kallioniemi A., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
11. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F., Gray J.W., Pinkel D. Comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
12. Jarošová M., Holzerová M., Jedličková K., Mihál V., Zuna J., Starý J., Pospišilová D., Zemanová Z., Trka J., Blažek J., Pikalová Z., Indrák K. Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet. 123:2000;114-122.
13. Riffenburgh R.H. Statistics in medicine. 1999;Academic Press, San Diego.
14. Altmann D.G. Practical statistics for medical research. 1991;Chapman and Hall, London.
15. Jarošová M., Holzerová M., Mihál V., Blatnú J., Lakomá I., Trka J., Pikalová Z., Hrusak O., Indrák K. Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene. Leukemia. 16:2002;1873-1875.
16. Jarošová M., Mihál V., Holzerová M., Jedličková K., Pospišilová D., Pikalová Z., Indrák K. Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL. Leukemia. 14:2000;1319-1322.
17. Cavé H., Cacheux V., Raynaud S., Brunie G., Bakkus M., Cochaux P., Preudhomme C., Lai J.L., Vilmer E. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia. 11:1997;1459-1464.
18. Andreasson P., Johansson B., Billström R., Garwicz S., Mitelman F., Höglund M. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements. Leukemia. 12:1998;390-400.
19. Mathew S., Shurtleff S.A., Raimondi S.C. Novel cryptic, complex translocations involving TEL-CBFA2 (TEL/AML1) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia. Genes Chromosomes Cancer. 32:2001;188-193.
20. Ma S.K., Wan T.S., Cheuk A.T., Fung L.F., Chan G.C., Chan S.Y., Ha S.Y., Chan L.C. Characterization of additional events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: molecular cytogenetic study. Leukemia. 15:2001;1442-1447.
21. Ford A.M., Fasching K., Panzer-Grümayer E.R., Koenig M., Haas O.A., Greaves M.F. Origin of "late" relapse in childhood acute lymphoblastic leukaemia with TEL-AML1 fusion genes. Blood. 98:2001;558-564.
22. Bargetzi M.J., Mühlematter D., Tichelli A., Jotterad M., Wernli M. Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukaemia. Cancer Genet Cytogenet. 113:1999;90-92.
23. Clark R., Byatt S.A., Brama M., Martineau M., Moorman A.V., Roberts K., Sacker-Walker L.M., Richards S., Eden O.B., Goldstone A.H., Harrison C.J. Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia. 14:2000;241-246.
24. Secker-Walker L.M. Chromosomes and genes in acute lymphoblastic leukaemia. 1996;Springer-Verlag, Heidelberg.
25. Gisselsson D., Hoglund M., Mertens F., Johansson B., Dal Cin P., Van den Berghe H., Earnshaw W.C., Mitelman F., Mandahl N. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet. 104:1999;315-325.
26. Heerema N.A., Sather H.N., Sensel M.G., Liu-Mares W., Lange B.J., Bostrom B.C., Nachman J.B., Steinherz P.G., Hutchinson R., Gaynon P.S., Arthur D.C., Uckun F.M. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood. 94:1999;1537-1544.
27. Greaves M.F., Chan L.C., Furley A.J., Watt S.M., Molgaard H.V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 67:1986;1-11.
28. Pui C.-H., Rubnitz J.E., Hancock M.L., Downing J.R., Raimondi S.C., Rivera G.K., Sandlund J.T., Ribeiro R.C., Head D.R., Relling M.V., Evans W.E., Behm F.G. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 16:1998;3768-3773.
29. Putti M.C., Rondelli R., Cocito M.G., Aricó M., Sainati L., Conter V., Guglielmi C., Cantú-Rajnoldi A., Consolini R., Pession A., Zanesco L., Masera G., Biondi A., Basso G. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood. 92:1998;795-801.
30. Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M.G., Ludig W.D., Burci L., Mangioni S., Schrappe M., Riehm H., Lampert F., Basso G., Masera G., Harbott J., Biondi A. Incidence and clinical relevance of TEL-AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood. 90:1997;571-577.
31. Hann I.M., Richards S.M., Eden O.B., Hill F.G. Analysis of the immunophenotype of children treated on the Medical Research Council UK Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia. 12:1998;1249-1255.
32. Den Boer M.L., Kapaun P., Pieters R., Kazemier K.M., Janka-Schaub G.E., Veerman A.J.P. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance. Br J Haematol. 105:1998;876-882.
33. Uckun F.M., Sather H.N., Gaynon P.S., Arthur D.C., Trigg M.E., Tuberger D.G., Nachman J., Steinherz P.G., Sensel M.G., Reaman G.H. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 90:1999;28-35.
34. Baruchel A., Cayuela J.M., Ballerini P., Landman-Parker J., Lezard V., Firat H., Haddad E., Auclerc M.F., Valensi F., Cayre Y.E., Macintyre E.A., Sigaux F. The majority of myeloid-antigen positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. Br J Haematol. 99:1997;101-106.